Post-approval studies (Phase 4)Ended earlyNCT04624672What this trial is testingTreatment of GLP-1 for Diabetic Bariatric PatientsWho this might be right forDiabetes Mellitus, Type 2 Geisinger Clinic 3
Not applicableStudy completedNCT03819972What this trial is testingThe Dose Response of Calcium Co-ingested With Protein on GLP-1 ConcentrationsWho this might be right forGLP-1 Concentration University of Bath 18
Post-approval studies (Phase 4)Study completedNCT03341429What this trial is testingEvaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 ResponseWho this might be right forObesity University College, London 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07760948What this trial is testingHMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideWho this might be right forType 2 Diabetes Mellitus (T2DM)SarcopeniaObesity+2 more Vanderbilt University Medical Center 90
Not applicableStudy completedNCT01507597What this trial is testingThe Effect of GLP-1 on the Inhibition of Glucagon SecretionWho this might be right forType 2 DiabetesType 1 Diabetes University Hospital, Gentofte, Copenhagen 30
Post-approval studies (Phase 4)Study completedNCT00859079What this trial is testingEfficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic PatientsWho this might be right forDiabetes Mellitus Type 2Hyperglycemia Medical University of Graz 8
Large-scale testing (Phase 3)Study completedNCT00905255What this trial is testingGLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)Who this might be right forDiabetes Mellitus, Type 2 Sanofi 69
Post-approval studies (Phase 4)Not Yet RecruitingNCT07755085What this trial is testingGLP-1s in Hip and Knee ArthroplastyWho this might be right forArthritisObesity & OverweightGLP - 1 Nova Scotia Health Authority 100
Post-approval studies (Phase 4)Study completedNCT02607410What this trial is testingSitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2DWho this might be right forType 2 Diabetes Mellitus University of Sao Paulo General Hospital 40
Post-approval studies (Phase 4)Study completedNCT04969627What this trial is testingEffects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.Who this might be right forPolycystic Ovary Syndrome Bing He 60
Early research (Phase 1)Not Yet RecruitingNCT07758231What this trial is testingImpact of GLP-1 Receptor Agonist Therapy on Alcohol PharmacokineticsWho this might be right forGLP-1Alcohol University of Wisconsin, Madison 5
Early research (Phase 1)Study completedNCT02204813What this trial is testingTo Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass SurgeryWho this might be right forBypass, GastricRoux-en-Y Gastric BypassVertical Sleeve Gastrectomy+2 more Washington University School of Medicine 13
Post-approval studies (Phase 4)Not Yet RecruitingNCT07554417What this trial is testingCombatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1Who this might be right forGLP - 1Obesity & OverweightMuscle Loss+2 more William Marsh Rice University 20
Post-approval studies (Phase 4)Study completedNCT02333591What this trial is testingEffect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in AdultsWho this might be right forCoronary Microvascular Dysfunction Mette Zander 25
Post-approval studies (Phase 4)Study completedNCT01404676What this trial is testingThe Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus Samsung Medical Center 34
Post-approval studies (Phase 4)Study completedNCT02299050What this trial is testingEffect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue TherapyWho this might be right forType 2 Diabetes The University of Texas Health Science Center at San Antonio 23
Not applicableStudy completedNCT03526289What this trial is testingGIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food IntakeWho this might be right forType 2 Diabetes MellitusOverweight and Obesity University Hospital, Gentofte, Copenhagen 22
Not applicableStudy completedNCT01391884What this trial is testingElimination of Incretin Hormones in Patients With Severe Kidney FailureWho this might be right forUremia Bo Feldt-Rasmussen 24
Post-approval studies (Phase 4)Study completedNCT06533527What this trial is testingHolding vs. Continuing Incretin-based Therapies Before Upper EndoscopyWho this might be right forDiabetes Mellitus, Type 2ObesityGastroparesis The Cleveland Clinic 69
Not applicableWithdrawnNCT01302327What this trial is testingGLP Analogs for Diabetes in Wolfram Syndrome PatientsWho this might be right forDiabetes Mellitus Associated With Genetic SyndromeWolfram Syndrome Hadassah Medical Organization